DH vs RARE · rev $111.1M vs rev $350.0M
Definitive Healthcare Corp (DH) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Definitive Healthcare Corp (DH) is a health information services company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported DH revenue for 2026-06-30 was $111.1M. Net income was -$144.0M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. DH currently screens at market cap $98.2M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
DH currently screens at market cap $98.2M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the DH and RARE stock pages for the full models.
Not investment advice.